- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2016
- Public Summary Document (PSD) November 2016 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2016 PBAC Meeting - Word
Nintedanib – November 2016
Nintedanib: Capsule 100 mg, Capsule 150 mg; Ofev®
Last updated
3 March 2017